Wednesday 9 June 2021
DRDO invites EoI to transfer technology of 2-DG drug for bulk production
The 2-DG was developed by the Institute of Nuclear Medicine and Allied Sciences, a lab of DRDO, in collaboration with Dr. Reddy’s Laboratories.
from The Hindu - Business
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment